Our differentiated cell lines, including cardiomyocytes derived from fibroblast-origin iPSCs, provide advanced research and therapeutic applications. Coriell’s expertise in differentiation protocols ensures that derived cell types retain their functional and molecular fidelity.
.jpg?mw=700&mh=700)
